Biomarker estimation using Multiplex platforms is built around robust and well known
Luminex xMAP technology. We perform multiplex study in diverse matrices such as
serum, plasma, and tissue culture supernatants.

Over 80+ scientists, around 20% of them having 20+ years of rich discovery experience
and healthy PhD’s to Masters ratio of 2:7 . Working together and sharing success.
Extension of your in-house discovery team at INDIA.

Customized Services

Facilities

Infrastructure

In a campuse of approximately 60000 square feet area Dabur Research Foundation is
a one-stop shop for your preclinical needs. The state-of-the-art GLP facility is
ready having 19 experimental rooms. This facility is centrally

Tissue Culture

DRF maintains a state-of-the-art self-contained tissue culture facility that houses
all equipment needed for the growth, maintenance, and analysis of cells. The facility
maintains its standard as one of the best facilities in India.

Testimonials

“Dabur Research Foundation has established an outstanding infrastructure and a highly motivated team for transnational research.”

Ravi Jasuja

Harvard Medical School and Brigham and Women's Hospital

“On behalf of the TSRL team, I would like to congratulate team DRF for providing a wonderful data in a transparent way, generated reports, other logistic supports and co-operation for the last two years.”

Snehasis Jana, PhD

General Manager

Trivedi Science Research Laboratory Pvt Ltd

“Thank you very much for sending the report of the HSC study. We are very satisfied with your detailed report and your work and would appreciate your further cooperation”

Philipp Peterburs, PhD

Junior Manager Preclinical R&D Bionorica SE

Bionorica SE

“Our association with Dabur Research Foundation was productive. Their scientific team and its capabilities are exemplary, they thoughtfully navigated obstacles along the way, and have allowed us to achieve the project objectives successfully. The team has shown a commitment to teamwork and collaboration in their efforts. I hope that we get a chance to work together in future also.”

Dr. Jan Alenfall

External CEO

Folium

“Thanks for your leadership in the last 5 year….I have no doubt we will get to the “promise land together”

Tal Dilian

Co-Founder

Sirbal

Our leadership team

Dr. Manu Jaggi

Chief Scientific Officer

Doctorate in Cancer Biology from National Institute of Immunology and a post graduate
in Pharmaceutical Science (Gold Medalist); Dr. Jaggi is a seasoned scientific leader
bringing over 20 years of successfully leading discovery research and advanced preclinical
drug development teams with special focus in global collaborative drug discovery
research.

Dr. Anu T. Singh

Vice President

Doctorate in Tumor Biology from All India Institute of Medical Science, and post
postdoctoral research in signal transduction alterations in adenocarcinomas at National
Institute of Immunology; Dr. Anu is a seasoned scientific leader with over 20 years
of comprehensive experience in new drug discovery and early preclinical drug development
and scientific operations with special interest in translatory research of photochemical
based products.

Dr. Manu Jaggi

Chief Scientific Officer

Doctorate in Cancer Biology from National Institute of Immunology and a post graduate
in Pharmaceutical Science (Gold Medalist); Dr. Jaggi is a seasoned scientific leader
bringing over 20 years of successfully leading discovery research and advanced preclinical
drug development teams with special focus in global collaborative drug discovery
research. He holds over 100 patents and led a successful discovery team which resulted
in a first-in-world clinical candidate Nanoxel™ (a polymeric Nanoparticle based
drug delivery system for Paclitaxel). Dr. Jaggi has published and presented over
40 research papers in peer-reviewed journals. He holds memberships in several scientific
committees and has attended and presented at several international and Indian conferences
and meetings.

Dr. Anu T. Singh

Vice President

Doctorate in Tumor Biology from All India Institute of Medical Science, and post
postdoctoral research in signal transduction alterations in adenocarcinomas at National
Institute of Immunology; Dr. Anu is a seasoned scientific leader with over 20 years
of comprehensive experience in new drug discovery and early preclinical drug development
and scientific operations with special interest in translatory research of photochemical
based products. Dr. Anu was instrumental in discovery and development of first-in-world
clinical candidate Nanoxel™ (a polymeric Nanoparticle based drug delivery system
for Paclitaxel). Anu holds over 14 US Patents and more than 46 in rest of the world
and several more in India. She has published and presented more than 30 research
papers in peer-reviewed journals & scientific meetings.